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a b s t r a c t
Vietnam has a unique history in association with foreign countries, which may have resulted in multiple
introductions of the alien HCV strains to mix with those indigenous ones. In this study, we characterized
the HCV sequences in Core-E1 and NS5B regions from 236 Vietnamese individuals. We identiﬁed
multiple HCV lineages; 6a, 6e, 6h, 6k, 6l, 6o, 6p, and two novel variants may represent the indigenous
strains; 1a was probably introduced from the US; 1b and 2a possibly originated in East Asia; while 2i, 2j,
and 2m were likely brought by French explorers. We inferred the evolutionary history for four major
subtypes: 1a, 1b, 6a, and 6e. The obtained Bayesian Skyline Plots (BSPs) consistently showed the rapid
HCV population growth from 1955 to 1963 until 1984 or after, corresponding to the era of the Vietnam
War. We also estimated HCV growth rates and reconstructed phylogeographic trees for comparing
subtypes 1a, 1b, and HCV-2.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Hepatitis C virus (HCV) is one of the major causative agents of
chronic liver disease. Globally, an estimated 3% of the world
population is chronically infected with the virus (Alter, 2007).
Chronic HCV infection signiﬁcantly increases the risk of liver
cirrhosis and hepatocellular carcinoma, which are associated with
substantial morbidity and mortality that are expected to increase
over the next decades (Jahan et al., 2012). According to a report
from the World Health Organization (WHO, 2012), countries with
high HCV prevalence include those in Africa and Asia (Perz et al.,
2006; Shepard et al., 2005; Sievert et al., 2011) such as Egypt
(14.7%) (Guerra et al., 2012), Pakistan (4.95%) (Waheed et al.,
2009), Thailand (3.2–5.6%) (Apichartpiyakul et al., 1999;
Songsivilai et al., 1997), and Vietnam (2–9%) (Nakata et al., 1994;
Tran et al., 2003).
Analysis of sequences has classiﬁed HCV into seven genotypes
(Smith et al., 2014). Except for genotypes 5 and 7, each of them is
further divided into multiple subtypes. Different genotypes and
subtypes of HCV have shown unique patterns of geographic
distribution. In general, subtypes 1a, 1b, 2a, 2b, and 3a are globally
distributed. In contrast, genotype 4 is primarily limited to indi-
genous populations in North Africa and the Middle East, 5a to
South Africa, and genotype 6 to Southeast Asia and IDUs and
expatriates from that region (Pybus et al., 2009, 2007). HCV
genotype is an important indicator for patient management
because its genetic variation patterns are associated with
responses to the therapy of pegylated interferon plus ribavirin
(Ahmad et al., 2011; Fried et al., 2002).
Recently, a large scale of HCV survey has been completed in
Vietnam, which screened 8654 individuals with different risk
factors in ﬁve geographic regions: Ha Noi, Hai Phong, Da Nang,
Khanh Hoa, and Can Tho. This study determined HCV genotypes
among 282 individuals and found that subtypes 1a (33%) and 1b
(27%) were the most common followed by 6a (18.8%), while other
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genotype 6 subtypes such as 6e (6.0%), 6h (4.6%), and 6l (6.4%) were
also frequent (Dunford et al., 2012). In contrast, subtypes 2a (0.4%),
3a (0.7%), and 3b (1.1%) were rare. In that study, however, neither
included individuals from Ho Chi Minh City, nor were the evolu-
tionary patterns analyzed. Therefore, the aim of the current article
was to estimate the HCV epidemic history and evolutionary
dynamics based on the sequences determined from the HCV-
infected individuals sampled in Ho Chi Minh City, the largest
population center in Vietnam and the one with the most possible
exposure to the US personnel during the Vietnam War. It is hoped
that the yielded results may add new insights to the current
understanding of the HCV infection and transmission in the country
and the given evolutionary estimates may be more informative than
the data obtained using the traditional approaches.
Results
Phylogenetic analysis
Core-E1 and NS5B sequences of HCV were determined in 236
subjects: 146 (61.86%) men, 86 (36.44%) women, and four with
unknown gender. All of them were Vietnamese and aged from 22
to 88, with a mean age of 46.13711.5. Figs. 1 and 2 show two
maximum likelihood (ML) trees in a circular form, reconstructed
using the obtained Core-E1 and NS5B sequences and co-analyzed
with 13 reference sequences representing 13 assigned subtypes
that were related to this study. Both trees revealed considerable
genetic diversity of HCV representing six major subtypes: 1a in 29
(12.3%), 1b in 48 (20.3%), 2a in 20 (8.5%), 2m in 12 (5.1%), 6a in 53
(22.5%), and 6e in 48 (20.3%). In addition, seven uncommon
subtypes were also detected: 6h in 2, 6k in 3, 6l in 6, 6o in 4, 6p
in 7, 2i and 2j each in one. Furthermore, two isolates, TV469 and
VN214, were classiﬁed under HCV-6, but their subtype could not
be determined (Table 1 and Fig. 1). As a whole, HCV-6 isolates
accounted for more than a half (53%). Consistently shown in both
trees, sequences of identical isolates were located in similar
positions and therefore, reliable sequencing results were con-
ﬁrmed and no recent viral recombination or mixed HCV infection
was suggested. In both trees, when a subtype cluster was formed,
a signiﬁcant bootstrap support of 481% was shown.
A possible new subtype
TV469 and VN214 may represent a new subtype. For veriﬁcation,
67 genotype 6 reference sequences were retrieved from GenBank and
co-analyzed, which generated additional two trees: one for the Core-
E1 (Fig. S1) and the other for NS5B (Fig. S2). Both trees showed TV469
and VN214 forming a close subset distinct from all other HCV-6
lineages. In Fig. S1, we also included 48 subtype 6e sequences
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Fig. 1. Circular form of phylogenetic tree based on the Core-E1 sequences from 236 study subjects co-analyzed with 13 references for 13 assigned subtypes. Different
subtypes are shown in different colors and indicated on the upper right corner of the tree, while clusters in black show minor subtypes with their labels post-ﬁxed.
All references are shown in purple with their format as: subtype_isolate ID_GenBank number. Close to the internal nodes of each cluster, two digit numbers show the values
of bootstrap analysis, of which only those Z81% are presented. In the center of the tree, a pie chart with its neighboring percentage shows the proportions of the different
subtypes of 236 isolates.
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determined in this study and they composed an extended but diverse
cluster. Interestingly, TV469 and VN214 appeared to be more relative
to 6e than to any other subtypes. Recently, partial NS5B sequences
have been characterized for many novel HCV-6 variants, which were
all sampled in Vietnam (Koletzki et al., 2010) and also co-analyzed in
Fig. S2 (blue branches). To a certain extent, ﬁve of these sequences
were more relative to TV469 and VN214. Among them, GU049374,
TV469, and VN214 appeared to form a closer lineage to loosely group
with GU049368, GU049385, GU049389, and GU049400 in forming a
larger subset. Via GU049381 as an intermediate variant, this larger
subset was adjacent to the 6e clade and as awhole theymay represent
an ancient subtype that was historically endemic in Vietnam.
Based on Figs. S1 and S2, pairwise nucleotide similarities were
calculated. In the Core-E1 and NS5B regions, TV469 and VN214
shared similarities of 94.1–94.8% with each other, suggesting
different strains of a single subtype. Comparing with 67 HCV-6
references, TV469 and VN214 showed similarities of 67.1–79.3% in
the Core-E1 and 68.1–79.4% in the NS5B region, while comparing
with GU049374 in NS5B, the similarities were 81.7–83.4%. These
similarities indicate different subtypes.
Evolutionary analysis
Based on the Core-E1 sequences of 1a, 1b, 6a, and 6e that each had
a percentage of more than 10% among the detected 236 isolates, four
evolutionary analyses were performed. The ﬁrst analysis used 29 1a
sequences with a prior rate of 9.1104. A BSP was given that
showed the median growth curve steadily increasing from 1963 until
1990.8 (Fig. 3, Table 2). Although this growth curve became slightly
slower after 1990.8, it remained to go up until the present. Since
considerable boundaries were included, a wide range of 95% highest
posterior density conﬁdence intervals (HPD) was given, particularly
from 1963 to 1980. The second analysis used 48 sequences of 1b with
a prior rate of 1.02103. The resulting BSP showed the median
growth curve going up from 1961 until 1985.1, yet after 1985.1 the
growth slowed to the present. The third analysis used 53 sequences of
6a with a prior rate of 1.116103. The resulting BSP showed an
almost identical pattern to that of 1b. However, the median growth
curve indicated the rapid HCV growth starting before 1958 up to
1984.2. The fourth analysis used 48 sequences of 6ewith a prior rate of
1.1646103. The resulting BSP showed a standard “S” shape of the
median growth curve. In the latter BSP, a relatively constant popula-
tion size was maintained before 1925 till 1950 that was followed by an
exponential population growth that continued to 1986.2 and then
slowed to the present.
Phylogeographic tree analysis
Phylogeographic trees for 1a and 1b showed slightly different
patterns. A noted feature for 1a is that the Vietnamese sequences
diverged between the mid-1950s and early 1960s, while many US
and a few European 1a clusters emerged later (Fig. S3). For 1b,
such time points, at which the Vietnamese sequences emerged,
were in a much wider range and appeared to be continual, from
the earliest in 1941 to the latest after 1971 (Fig. S4). In addition, the
Vietnamese 1b clusters had more complicated internal branches
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Fig. 2. Circle form of phylogenetic tree based on the NS5B sequences from 236 study subjects co-analyzed with 13 references for 13 assigned subtypes. Except that no
signiﬁcant bootstrap supports were shown and the central pie chart was surrounded with the number of sequences each lineage possesses, all other indications are the same
as described in Fig. 1.
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than those of 1a. Collectively, these would suggest more active
divergences and perhaps a longer duration of circulation of the
Vietnamese 1b than 1a isolates.
After classifying 1a sequences into three groups (US, Europe,
and Vietnam) and 1b into four (US, Europe, China, and Vietnam),
both trees were tested for two tree-shape statistics, AI (Association
Index) and PS (Parsimony Score), which showed values strongly
rejecting the null hypothesis of panmix (Parker et al., 2008; Slatkin
and Maddison, 1989). Thus, the existence of the geographic
clusters is strongly supported. In fact, these geographic clusters
can be steadily seen in both trees, particularly for 1a, in which
three Vietnamese clusters were separable from those of the US
and Europe. Vietnamese clusters were also seen in the tree for 1b,
although many sequences from the US and Europe appeared to
mix. Based on these Vietnamese 1a and 1b geographic clusters, the
most recent common ancestors (tMRCAs) were estimated by
additional BEAST analyses, which showed the times of origin in
1950 (95% HPD: 1938, 1960), 1947 (95% HPD: 1934, 1961), and 1958
(95% HPD: 1947, 1968) for three 1a clusters, and 1948 (95% HPD:
1936, 1959), 1937 (95 HPD: 1918, 1953), and 1940 (95% HPD: 1928,
1953) for three 1b clusters, with the emergences of 1b earlier
than 1a.
Similarly, phylogeographic trees were reconstructed for sub-
types 2a and 2m as well (Figs. S5 and S6), but the results were
described and discussed in the Supplementary data.
Growth rate estimation
The four BSPs generated using Tracer may not show clear
patterns of growth curve for indicating different growth periods
(Fig. 3). However, after a natural logarithmic transformation of the
median population sizes exported from the BSP log ﬁles, such
patterns appeared to be obvious (Fig. 4). Based on the transformed
growth curves, two growth periods, the rapid growth and the
continuous growth, were mathematically divided at the time
points where the largest sum of r2 of regression was seen
(Table 3). The result was that the rapid growth was delimited
from 1963 to 1990.8 for 1a, from 1961 to 1985.1 for 1b, from 1958
to 1984.2 for 6a, and from 1949.8 to 1986.2 for 6e, while the
continuous growth was denoted thereafter to the present (Fig. 3).
Using simple linear regression to analyze the median population
sizes within these two growth periods, growth rates were esti-
mated that are equal to the regression slopes (Fig. 4). Within the
period of rapid growth, the slopes (slope 1) were 0.087, 0.193,
0.182, and 0.136 for 1a, 1b, 6a, and 6e, respectively. Within the
period of continuous growth, the slopes (slope 2) were 0.034,
0.041, 0.039, and 0.029 (Table 3). Using slope 1 as a prior to further
estimate the same datasets by running the BEAST program under
the constant logistic model (Pybus et al., 2003), more precise
HCV growth rates (mean795% conﬁdence intervals) were esti-
mated within the period of rapid growth: 0.2295 (95% CI: 0.1351,
0.343) for 1a, 0.3581 (95% CI: 0.212, 0.5203) for 1b, 0.3001 (95% CI:
0.184, 0.4233) for 6a, and 0.2494 (95% CI: 0.1386, 0.3702) for 6e
(Table 3).
Discussion
In this study, we characterized the HCV sequences from 236
individuals in Ho Chi Minh City. Phylogenetic analysis revealed a
high degree of genetic diversity, conﬁrming the polyphyletic
nature of HCV in Vietnam. Thirteen subtypes 1a, 1b, 2a, 2i, 2j,
2m, 6a, 6e, 6h, 6k, 6l, 6o, 6p, and two novel genotype 6 variants
were characterized with sequences congruently determined from
two separated genomic regions. Among them, genotypes 1 and
6 were predominant, accounting for 32.63% (77/236) and 52.97%Ta
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Table 2
Statistics generated from Bayesian MCMC analyses for estimating our BSPs.
BSP 1aa (n¼29) 1bb (n¼48) 6aa (n¼53) 6ea (n¼48)
Rate Priorc N (9.1025E-4, 1E-5) N (1.018E-3,1E-5) N (1.1632E-3,1E-5) N (1.1646E-3,1E-5)
Posteriord 3228.6270.21 5135.3370.31 6827.1370.42 6413.7470.31
(3255.38, 3202.82) (5166.31, 5105.38) (6858.84, 6794.64) (6441.25, 6385.22)
Alpha 1.449672.22E-2 0.708377.36E-3 0.908273.23E-3 1.093773.51E-3
(0.27, 2.78) (0.33, 1.14) (0.6, 1.23) (0.7, 1.47)
pInv 0.573.65E-3 0.472.63E-3 0.4477.48E-4 0.4576.51E-4
(0.33, 0.62) (0.25, 0.51) (0.37, 0.51) (0.38, 0.51)
Uced.mean 9.10E-0471.16E-07 1.02E-0371.04E-07 1.16E-0371.10E-07 1.16E-0371.04E-07
(8.90E-04, 9.29E-04) (9.99E-04, 1.04E-03) (1.14E-03, 1.18E-03) (1.15E-03, 1.18E-03)
COV 0.7271.44E-03 0.7371.39E-03 0.7071.15E-03 0.7071.49E-03
(0.58, 0.88) (0.6, 0.87) (0.59, 0.83) (0.57, 0.85)
tMRCAs 83.7870.53 79.9770.4 78.1170.43 168.2871.35
(48.12, 129.67) (49.27, 115.79) (53.1, 110.24) (87.76, 294.04)
Covariance 0.0471.37E-03 0.0271.17E-03 0.0879.74E-04 0.0771.16E-03
(0.29, 0.21) (0.22, 0.18) (0.26, 0.09) (0.25, 0.12)
Treelikelihood 3069.3470.08 4827.1570.16 6446.4370.23 6062.8770.18
(3082.31, 3055.9) (4845.3, 4809.77) (6466.04, 6427.12) (6081.18, 6045.46)
a A normal rate estimated for the actual dataset in this study.
b A normal rate estimated in this study for an alternative 1b dataset.
c Normal distribution (mean, lower and upper boundaries).
d Mean7Standard error of mean (upper and lower 95% conﬁdence intervals).
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Fig. 3. Bayesian Skyline Plots. Four diagrams represent four subtypes 1a, 1b, 6a, 6e. The solid line represents the effective population size through time. The purple area
represents the 95% highest posterior density conﬁdence interval. The vertical ruler on the left (Y axis) measures the effective population size while the horizontal scale on the
bottom measures time from the present (right) to the past (left).
Table 3
Statistics related to the estimates of growth rates.
Subtype (prior molecular rate) BSP regression slope conLog.growthRated conLog.t50
Slope 1a Intercept 1a Switch pointb Slope 2c Intercept 2c Mean 95% l ower 95% upper Median
1a (9.1025E-4) 0.087 166.658 1990.81 0.034 60.4199 0.2295 0.1351 0.343 0.2232 34.335
1b (1.018E-3) 0.193 428.18 1985.12 0.041 63.23 0.3581 0.212 0.5203 0.3499 34.125
6a (1.1632E-3) 0.182 381.24 1984.18 0.039 57.11 0.3001 0.184 0.4233 0.2929 33.916
6e (1.1646E-3) 0.136 283.02 1986.18 0.0292 48.77 0.2494 0.1386 0.3702 0.2416 34.036
a Estimated for the period of rapid exponential growth.
b The best-ﬁtting time point at which the sum of r² of two regression analyses maximized, which divides the periods of rapid growth and continuous growth.
c Estimated for the period of continuous growth.
d Estimated under the constant logistic model using BEAST.
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(125/236), respectively. Although genotype 2 was at 18.64%
(44/236), some isolates were exclusively detectable in Vietnam.
Different from other studies in Southeast Asian countries
(Hubschen et al., 2011; Jutavijittum et al., 2009; Shinji et al.,
2004; Sistayanarain et al., 2011) including those from Vietnam
(Dunford et al., 2012; Pham et al., 2009; Tanimoto et al., 2010), the
proportions of 1a, 1b, 6a, and 6e were compatible while no
genotype 3 was detectable, consistent with a recent report
(Pham et al., 2011). These isolates constituted a unique HCV
genotype distribution pattern, characteristic of a long-term ende-
mic circulation mixed with subsequent multiple introductions of
alien strains.
The ﬁrst ﬁnding is a high percentage of HCV-6 isolates (53%,
125/236) and among them 6a is predominant accounting for 42.4%
(53/125). Although 6a was ﬁrst discovered in Hong Kong (Adams
et al., 1997; Bukh et al., 1992), more divergent 6a isolates
were later sequenced from blood donors in Ho Chi Minh City
(Tokita et al., 1994). Currently, 6a infections are common in
Thailand, Myanmar, and China, and also detectable among Asian
immigrants in North America. Recently, we studied 6a migration
patterns in China and included many 6a sequences from Vietnam
as references that were determined from the cohort reported here
(Fu et al., 2012).
Among the detected HCV-6 isolates, 6e was the second pre-
dominant (38.4%, 48/125). Two features were noted for 6e:
(1) genetically highly diverse and complex; (2) often detected in
Vietnam and occasionally in the neighboring China, Thailand, and
Cambodia, and in Asian immigrants in north America as well
(Akkarathamrongsin et al., 2010, 2011; Murphy et al., 2007;
Noppornpanth et al., 2006; Pham et al., 2009; Tokita et al., 1994).
According to these features, we believe that 6e has been long
indigenous to Vietnam and subsequently spread to the neighboring
countries. For example, via the known drug trafﬁcking routes, it has
spread and become locally epidemic in Guangxi province in China
bordering Vietnam (Garten et al., 2005).
Subtypes 6h, 6l, 6k, 6o, and 6p were also detected. In addition,
two variants TV496 and VN214 were identiﬁed that may qualify
for a new subtype. With the inclusion of subtypes 6b, 6d, 6j, 6q, 6t,
and many unclassiﬁed variants archived in GenBank, a wide
spectrum of HCV-6 members can be represented, indicating
a long endemic circulation and perhaps, the earliest origin of
HCV-6 in Vietnam.
New HCV-6 variants continue to be identiﬁed and the majority
were detected in Vietnam (Lu et al., 2008; Murphy et al., 2007). A
proposal for a uniﬁed HCV nomenclature has detailed the guide-
lines for classifying a new subtype. Minimally, it requires three
closely related isolates independently identiﬁed with sequences
differing from known subtypes by 15% of nucleotides in both Core/
E1 and NS5B regions, while the three should group consistently
using different methods (Simmonds et al., 2005; Smith et al.,
2014). According to this premise, both VN214 and TV469 may
represent a new subtype, since they had nucleotide similarities of
94.1–94.8% in Core-E1 and NS5B regions while differing from other
HCV-6 lineages by nucleotides of 16.6–32.9%. Furthermore, they
showed no recent viral recombination events. However, since they
lack the minimal three closely related isolates detectable, the
provisional designation of a new subtype is premature at the
moment.
The second ﬁnding is that subtype 1a accounted for 12.3% (29/236).
Although this is lower (Po0.05) than 23.7–33.0% recently reported for
1a detected among various patients from other regions in Vietnam
(Dunford et al., 2012; Pham et al., 2009; Tanimoto et al., 2010), such a
rate is still high. We are not certain if this was predicted by different
compositions of the study subjects who, at different ages or with
varied risk factors, may show preference for different HCV subtypes.
However, due to the lack of patient information, we were unable to
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Fig. 4. HCV growth rates. Four simpliﬁed diagrams correspond to four BSPs. In each diagram, the median growth curve is shown in red, in which a dot represents a sampling
time point. This curve is measured by the vertical ruler for population size on the left and the horizontal time scale on the bottom. The time course of HCV growth is divided
into two periods: rapid growth (yellow area) and continuous growth (gray area). For different subtypes, the delimitation of these two periods is dissimilar. Based on the
median population sizes exported from the four BSPs within these two periods, simple piecewise linear regression analyses were performed and the regression lines are
shown separately and appear in each diagram with two discontinued black lines. Accordingly, two regression functions and two r-squares are provided in each diagram, in
which the slopes indicate the growth rates. In each diagram, a blue curve is also presented, reﬂecting the changes in the sum of r-squares generated after sliding two
regression analyses through all sampling time points within a certain range. Measured by the vertical ruler on the right, this curve identiﬁes the best time point at which the
sum of R-squares maximizes and two growth periods are thereby divided. Because the BSP for 6e has an additional period of constant population size prior to its rapid
growth, three black and two blue curves are shown.
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assess this. Subtype 1a represents the major strain in the US (51.6%)
(Nainan et al., 2006). In contrast, it is rare in China (2.1%) (Fu et al.,
2011), Myanmar (4.1%) (Lwin et al., 2007), and Cambodia (2.3%, our
unpublished data), and has been never reported in Laos. Regardless, it
is common in Thailand (14.3%) (Jutavijittum et al., 2009) and more
common in the Philippines (34–36%) (Katayama et al., 1996; Maramag
et al., 2006). Between the latter two countries, there appears to be an
association of 1a prevalence with the interactions from the US. A
relatively high frequency of 1a in Vietnam may have reﬂected such
interactions during the Vietnam War.
The third ﬁnding is a relatively low proportion of subtype 1b
(20.34%, 48/236). This subtype accounts for approximately 66% of
the HCV infections in China (Lu et al., 2005), 64.4% in Japan, and
66% in South Korea (Ohno et al., 1997). It is also one of the major
subtypes in Europe (Esteban et al., 2008).
A number of unique HCV-2 isolates were detected. These
included 12 isolates of subtype 2m and one each of 2i and 2j.
Recently, we summarized the HCV-2 sequences from GenBank
(Li et al., 2012). We noted that 2m had origins exclusively in
Vietnam (Fig. S6) (Newman et al., 2012), while 2i and 2j were not
only detectable in Vietnam but also in France and other countries,
such as 2i in Germany, Canada, and Morocco (Li et al., 2012) and 2j
in Spain (Holland et al., 1996) and Venezuela (Sulbaran et al., 2010).
According to these data, we may hypothesize that all HCV-2 strains
had their ancestral origins in Africa (Li et al., 2012). However, they
were brought outside Africa most likely by European explorers
(Markov et al., 2012). Since Vietnam was a French colony over a
century, these HCV-2 strains were likely introduced via exposure to
foreign nationals. This is consistent with the recent ﬁndings that
many HCV-2 strains were detected in Indonesia, Canada, France,
Martinique, and the island of Hispaniola. Subtype 2m has been only
found in Vietnam but never in other countries, which may be due to
a limited sampling in Africa, particularly in those countries that are
also former French colonies (Sulbaran et al., 2010).
Four BSPs were generated. They consistently showed the rapid
HCV population growth from about 1950 to 1963 until 1984 or
after. Largely, this time frame corresponded to the Vietnam War
and the Third Indochina War (Tucker, 1999) (http://www.ushis
tory.org/us/55.asp). The former war started in 1954, escalated in
the early 1960s with the US involvement in South Vietnam, and
ended in April 1975, marked by the fall of Saigon, which is now
called Ho Chi Minh City, where all of the study subjects for this
study were recruited. However, the latter war occurred only in the
North and was in a small-scale and short-lived, which started and
ended in 1979.
The median growth curve of the 1a-BSP did not show a clear
separation of different phases. Instead, it exhibited a continuous
growth in HCV-infected population size, though with a slight
slowing around 1990. The beginning of 1a-BSP in 1963 may
correspond to the time point when 1a strains, likely originating
in the US, were introduced to Vietnam and rapidly added to the
number of new cases during wartime. The 1a growth was main-
tained even after the war, likely because this alien strain has been
ﬁrmly seeded and then become epidemic among the local popula-
tion. Such a presumption may explain why the ﬁrst half of the
median growth curve of the 1a-BSP presented a pattern similar to
that was previously estimated for the 1a growth in the US (Nakano
et al., 2004). However, there could be additional reasons for the
continuous growth represented by the second half of the median
growth curve that remained to rise even after 1990, although in a
slower slope (S2¼0.034). In a previous report, a marked slowing
in the increase in 1a-infected population size in the US was also
seen around 1990, which has been attributed to the discovery of
HCV in 1989 and a subsequent implementation of HCV screening
assays in 1990 (Nakano et al., 2004). In war-time Vietnam, a large
number of people were wounded and many may have been
infected with the alien 1a strains due to exposure to blood
products and medical services provided by foreign personnel. In
post-war Vietnam, HCV-contaminated blood transfusions
remained a serious problem until a policy of voluntary unpaid
blood donation was enforced by the government in recent years,
which has ﬁnally resulted in a steady rise in the proportion
of blood donors who have passed the mandatory screening for
HIV, HBV, and HCV (http://www.who.int/mediacentre/factsheets/
fs279/en/index.html). Regardless, a reservoir of 1a-infected people,
established during the war-time, continued to spread the infection
in the general population and contributed to the continuous
increase in the incidences of HCV transmissions, as presented by
the current 1a-BSP.
In comparison, the start of 1b-BSP appeared to be slightly
earlier than 1a and the start of 6a earlier than 1b (Fig. 3). This is
consistent with the fact that 1b represents the major subtype in
Asia and 6a is a local epidemic lineage in Vietnam (Dunford et al.,
2012; Pham et al., 2009; Tanimoto et al., 2010). Phylogeographic
tree analysis further showed that the Vietnamese 1b clusters had
older tMRCAs and more complicated internal branches than the
Vietnamese 1a clusters. This result corroborates a previous ﬁnding
that the global expansion of 1b preceded that of 1a by at least 16
years (Magiorkinis et al., 2009). Based on the analyses in this
study, it may be thought that 1b and also 6a represent the pre-
existing HCV lineages sharing very similar BSP patterns, and both
grew at faster rates than that seen with subtype 1a (Slope 1:
1b¼0.193, 6a¼0.182, 1a¼0.087), especially during war time.
However, following the end of the war, 1984 and after, the growth
became much slower, yet they remained on the rise to the present
time, at similar rates among subtypes (Slope 2: 1b¼0.041,
6a¼0.039, 1a¼0.034). Compared with 1a, 1b, and 6a, the 6e
growth was preceded with an extended period of constant
population size from 1930 to 1950, while the pattern of its rapid
growth during the war time was highly similar to that of 1b and
6a. Hence, 6e is characteristic of a long-term endemic circulation
with a rapid growth during the war. The indigenous circulation of
6e is also supported by the fact that 6e sequences are genetically
diverse (Figs. S1 and S2) and almost exclusively determined in
Vietnam (http://hcv.lanl.gov/).
The BSPs for 1a and 1b both showed wide ranges of errors from
their beginning to about 1985 (Fig. 3). One of the potential
meanings of such proﬁles is that, under the used prior rates and
credible intervals, the hypothesis of a constant size population
cannot be ruled out. In other words, because the molecular clock
information is not conclusive enough, these proﬁles may suggest
the lack of HCV fast population growth. With no knowledge about
how much these errors reﬂected the statistical uncertainties, nor
obtaining the information about the dates when the HCV infec-
tions had been acquired by those individuals from whom we
sampled 1a and 1b sequences, and the unavailability of the
historical data to show the overtime changes of HCV prevalence
in the general population in Vietnam, we are now ﬁnding difﬁcult
to draw any conclusion that is free from controversies. However,
the fast growth of 1a and 1b can be suggested by ﬁndings from
other studies in two aspects. In the ﬁrst aspect, based on 1a and/or
1b sequences sampled globally or in countries, patterns of fast
HCV growth have been indicated. These patterns largely corre-
sponded to what we estimated in this study, although to a certain
extent their starting and ending dates varied (Nakano et al., 2004;
Lu et al., 2013; Magiorkinis et al., 2009). Based on a short NS5B
region sequenced, similar BSP patterns have been also estimated
for 1a and 1b strains sampled in Vietnam. The results showed that
the 1a growth started around 1960s, while the 1b growth was
slower but started earlier in 1920 (Nakano et al., 2004). In another
study at the global level, robust estimates have been provided;
they indicated the massive expansion of 1a and 1b strains between
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1940 and 1980. While the earliest divergences of 1a and 1b
occurred in developed countries, the subsequent spread to devel-
oping countries appeared more often in the recent decades
(Magiorkinis et al., 2009). From the latter study, the estimated
time frame implied the global transmissions of 1a and 1b being
likely initiated and sustained by the increase of parenteral iatro-
genic procedures during and after World War II, for which blood
and lyophilized pooled plasma could have served as important
vehicles (Power et al., 1995). Via these vehicles, large numbers of
1a and 1b transmissions could have also occurred during the
Korean War (Kendrick, 1964) and the Vietnam War (Neel, 1991).
The fast growth of 1a and 1b also coincided with the history of
illicit IDU. While in the developed countries the heroin use by
means of IDU peaked in 1960s, such an activity is relatively recent
in many Asian countries including Vietnam (Stimson, 1993). Since
1a is more related to IDU (Rosen et al., 1999) while 1b is
preferentially transmitted by transfusions and unsafe medical
injections (Dubois et al., 1997; Pawlotsky et al., 1995), it may be
speculated that a considerable portion of the 1a introductions into
Vietnam were mediated via IDU, particularly by the US soldiers
during the war. Of the studies in the second aspect, the earliest
one reported an anti-HCV prevalence of 9% among the inhabitants
in Ho Chi Minh City who were not with any liver disease (Nakata
et al., 1994). In 2003, a much lower rate of 2% was revealed among
the healthy people in the same city (Tran et al., 2003). Never-
theless, both rates were higher than 1% that was later reported in
another study based on the randomly sampled general population
in a rural area in proximity to the city (Nguyen et al., 2007). These
rates may be not comparable, because they were from different
reports. However, they may have reﬂected a temporal decreasing
trend of HCV prevalence in the recent decades in Ho Chi Minh City
where we had collected samples for this study. Such a trend is
consistent with our BSP estimates that showed lower HCV growth
since 1990 and after, and hence implies a fast HCV growth period
before 1990.
Previous studies have reported a series of HCV growth rates
during the period of rapid growth: 0.25 for genotype 4 in Egypt
(Pybus et al., 2003), 0.1 for 1a and 3a in the US and UK,
respectively (Pybus et al., 2005; Tanaka et al., 2006), and 0.17 for
6a in Hong Kong (Tanaka et al., 2006). In this study, we estimated
the median growth rates for the four major HCV subtypes in
Vietnam during their periods of rapid growth, using a parametric
model in BEAST. This gave the 1b rate (0.3499) higher than 6a
(0.2929), then 6e (0.2416), and then 1a (0.2232). The 6a and 6e
rates are both higher than that of 6a in Hong Kong, and the 1a rate
higher than that of 1a in the US. Although they may somehow
reﬂect the increased incidences of HCV transmission during the
20-year-long Vietnam War, these rates were not as high as those
we have recently reported in China (Lu et al., 2013). Although the
VietnamWar was believed to be the signiﬁcant historical event for
ﬁnding the currently seen high HCV prevalence in Vietnam, the
induced incidences of HCV transmission appeared to be moderate.
This may be due to the lack of a marked rise in birth rate and many
casualties caused by the war that resulted in a smaller population
size at risk for HCV infection. However, in the postwar era a great
level of HCV transmissions were maintained in Vietnam, as
represented by the growth rates estimated during this period for
the four HCV subtypes: 0.034 for 1a, 0.041 for 1b, 0.039 for 6a, and
0.032 for 6e. It is implied that some common reasons for HCV
transmission and dissemination have not been removed, which
requires additional measures to be taken, not only for preventing
HCV transmission but also for improving the general condition of
public health.
It should be noted that the effective population size was
represented as base 10 logarithm in the four BSPs, and it was also
represented so in the “piecewise logistic” population model.
However, we used regression to produce the slopes (growth rates)
after a natural logarithmic transformation for the purpose to show
more obvious switches of the growth curves for the mathematical
division of the growth periods. Therefore, the estimated two
growth rates, one by regression analysis and the other by using
a parametric model, are not directly comparable. Further extra-
polation of these estimates should consider their differences.
Materials and methods
Subjects and specimens
Serum samples were obtained from 236 individuals infected
with HCV. These individuals included blood donors and patients
with liver disease. They were recruited by the Cho Ray Hospital,
the Hospital for Tropical Diseases, and the University of Medicine
and Pharmacy, all in Ho Chi Minh City, Vietnam. Informed consent
for participation in this study was obtained from each individual.
The ethical review committees of the above three institutes in
Vietnam and the University of Kansas Medical Center in USA and
the National Institute of Infectious Diseases in Japan approved
this study.
Sequence ampliﬁcation and genotyping
The ampliﬁed Core-E1 and NS5B sequences of HCV correspond
to the nucleotide numbering 739-1310 and 8267-8630 in the H77
genome. These sequences were determined as previously
described (Fu et al., 2011; Lu et al., 2005) followed by co-
analyses with 13 reference sequences representing 13 subtypes
that were detected in this study. These references were selected
based on the recommendations in a recent paper by Smith et al.
(2014). Prior to phylogenetic analysis, the best-ﬁtting substitution
model was tested using the jModeltest program (Posada, 2008)
according to the Akaike Information Criterion, which indicated
that GTRþ IþΓ was the best model for both Core-E1 and NS5B
datasets. Under this model, ML trees were heuristically searched
using the SPR (Subtree Pruning and Regrafting) and NNI (Nearest
Neighbor Interchange) algorithms in PhyML (Guindon and
Gascuel, 2003). With the tree ﬁles generated and applied to the
Figtree program (version 1.4) (Pybus and Rambaut, 2009), tree
topology was displayed and converted into a circular form. To
characterize the novel genotype 6 variants, 67 references were co-
analyzed (see Supplementary data for their selections). Based on
these resulting datasets, recent virus recombination events were
excluded using the RDP3 program under the settings as previously
described (Lu et al., 2008).
Evolutionary analysis
HCV evolutionary history was estimated for subtypes 1a, 1b, 6a,
and 6e, using the Markov Chain Monte Carlo (MCMC) algorithm in
the BEAST package (version 1.7.1). Brieﬂy, the best combination of the
GTRþ IþΓ substitution model, the Bayesian skyline coalescent
model, and the uncorrelated exponential clock model was used on
the basis that it always outperforms other combinations (Drummond
et al., 2012; Fu et al., 2012; Pybus et al., 2009), after a formal model
test that showed the ln Bayes factors ranged between 1.98 and 25.82.
However, we included different evolutionary rates as priors. Through
directly estimating the sequences determined in this study using the
Path-o-gen software (http://tree.bio.ed.ac.uk/software/pathogen), we
obtained four such rates, 9.1025104 substitution/site/year for 1a,
0.6103 for 1b, 1.163103 for 6a, and 1.1646103 for 6e.
Because the 1b rate was negative, it was discarded. Instead, we used
a rate of 1.02103 that we have recently estimated, based on an
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alternative 1b dataset (Yuan et al., 2013). To allow for adequate
statistical uncertainties, we set a credible interval at 1105
substitution/site/year in the BEAST analyses.
To explore the phylogeographic nature of 1a, 1b, 2a, and 2m
sequences resulting from this study, additional BEAST analyses were
performed after the addition of a number of reference sequences
followed by testing using Beﬁ-BaTS (www.lonelyjoeparker.com/?
tag=beﬁ-bats). The references included 176 1a, 166 1b, 52 2a, and 46
HCV-2 sequences (see Supplementary data for their selections).
To compare the differences in the patterns of HCV population
growth among subtypes, HCV growth rates were estimated within
the periods of rapid growth and continuous growth. We ﬁrst
exported a BSP log ﬁle using Tracer to obtain the median number
of HCV effective population sizes and then used this information in
a simple piecewise linear regression analysis, from which the
generated slope measures the speed of HCV population growth. To
show the obvious switches of growth curve, we performed a
natural logarithmic transformation to the number of HCV effective
population sizes and re-scaled the BSP for inspection, in which
each dot represents a sampling time point. To divide the periods of
rapid growth and continuous growth mathematically, we started
two regression analyses on both sides of a certain time point and
then slid this procedure through all the time points in the
exported BSP log ﬁle within a certain range, under the condition
that these analysis each contained at least 10 time points while the
two analyses covered the full range of the two growth periods.
This sliding procedure generated a series of sum of r2 correspond-
ing to the time points in the given range. Based on these sums of
r2, a curve was drawn and was used to identify the time point at
which the sum of r2 maximized. The latter indicates that two
regression analyses divided by this time point are the best-ﬁtting
among all. For simplicity, we wrote an R script for each BSP to run
all of these procedures automatically (R Core Team, 2013). To
obtain more precise HCV growth rates with their 95% conﬁdence
intervals, we ran the BEAST program under a “parametric” con-
stant logistic model as recently described (Lu et al., 2013).
After the above parameters were set using the BEAUti program,
XML ﬁles were generated and applied to the BEAST program
(Fu et al., 2012; Yuan et al., 2013). The latter ran MCMC procedures
each for 300 million states and output a tree every 10,000 states.
To assess the MCMC sampling convergence, the estimated effec-
tive sampling sizes (ESS) were evaluated. In this study, when all of
the ESS numbers were Z200, sufﬁcient sampling was considered
to have been achieved. To interpret the MCMC chains and output
posterior trees, the Tracer program (version 1.5) was used. To
generate phylogeographic trees in a decreasing node order, the
resulting posterior tree ﬁles were deciphered using the Figtree
program (version 1.4).
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